Brief: Oncopeptides Decides On Rights Issue Of About SEK 314 Mln
April 8 (Reuters) - Oncopeptides AB ONCO.ST :
* ANNOUNCES FINAL TERMS FOR FULLY GUARANTEED RIGHTS ISSUE
* SUBSCRIPTION PRICE HAS BEEN SET TO SEK 2.60 PER ORDINARY
SHARE
* BOARD OF DIRECTORS HAS DECIDED TO CARRY OUT A FULLY
GUARANTEED
RIGHTS ISSUE OF APPROXIMATELY SEK 314 MILLION, SUBJECT TO
APPROVAL BY EXTRAORDINARY GENERAL MEETING ON 15 APRIL 2024
Source text for Eikon: ID:nMFN7fQqW5
Further company coverage: ONCO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy